IL225892A0 - Formulations containing polyethylene glycol - Google Patents

Formulations containing polyethylene glycol

Info

Publication number
IL225892A0
IL225892A0 IL225892A IL22589213A IL225892A0 IL 225892 A0 IL225892 A0 IL 225892A0 IL 225892 A IL225892 A IL 225892A IL 22589213 A IL22589213 A IL 22589213A IL 225892 A0 IL225892 A0 IL 225892A0
Authority
IL
Israel
Prior art keywords
formulations
polyethylene glycol
glycol
polyethylene
Prior art date
Application number
IL225892A
Other languages
English (en)
Hebrew (he)
Original Assignee
Peter Stein
Ian Cox
Norgine Bv
Samuel Smith
Leighton Jones
Jorg Plessl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1018647.6A external-priority patent/GB201018647D0/en
Priority claimed from GBGB1104049.0A external-priority patent/GB201104049D0/en
Priority claimed from GBGB1107626.2A external-priority patent/GB201107626D0/en
Application filed by Peter Stein, Ian Cox, Norgine Bv, Samuel Smith, Leighton Jones, Jorg Plessl filed Critical Peter Stein
Publication of IL225892A0 publication Critical patent/IL225892A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL225892A 2010-11-04 2013-04-22 Formulations containing polyethylene glycol IL225892A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1018647.6A GB201018647D0 (en) 2010-11-04 2010-11-04 Formulations
US41210910P 2010-11-10 2010-11-10
GBGB1104049.0A GB201104049D0 (en) 2011-03-09 2011-03-09 Formulations
GBGB1107626.2A GB201107626D0 (en) 2011-05-06 2011-05-06 Formulations
PCT/GB2011/001560 WO2012059724A1 (en) 2010-11-04 2011-11-04 Formulations comprising polyethylene glycol

Publications (1)

Publication Number Publication Date
IL225892A0 true IL225892A0 (en) 2013-06-27

Family

ID=44999794

Family Applications (1)

Application Number Title Priority Date Filing Date
IL225892A IL225892A0 (en) 2010-11-04 2013-04-22 Formulations containing polyethylene glycol

Country Status (20)

Country Link
US (3) US20130225692A1 (enExample)
EP (1) EP2635264B8 (enExample)
JP (1) JP5872573B2 (enExample)
KR (1) KR20130101102A (enExample)
CN (1) CN103384516B (enExample)
AR (1) AR083769A1 (enExample)
AU (1) AU2011324995B2 (enExample)
BE (1) BE1019493A3 (enExample)
BR (1) BR112013010884A2 (enExample)
CA (1) CA2816835A1 (enExample)
EA (1) EA024566B1 (enExample)
ES (1) ES2405531B1 (enExample)
IL (1) IL225892A0 (enExample)
MX (1) MX342181B (enExample)
MY (1) MY164204A (enExample)
NL (1) NL2007716C2 (enExample)
NZ (1) NZ611148A (enExample)
SG (1) SG190018A1 (enExample)
TW (1) TWI520730B (enExample)
WO (1) WO2012059724A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
WO2013119582A1 (en) * 2012-02-06 2013-08-15 University Of Utah Research Foundation Drug release from a polymer-controlled local antibiotic delivery system using a degradable bone graft
AR092500A1 (es) 2012-09-11 2015-04-22 Norgine Bv Solucion de limpieza de colon
US9889235B2 (en) 2013-02-05 2018-02-13 University Of Utah Research Foundation Implantable devices for bone or joint defects
JP6441890B2 (ja) 2013-03-15 2018-12-19 ブレインツリー・ラボラトリーズ,インコーポレイテッド 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
BR112016025481A2 (pt) 2014-04-29 2017-08-15 Colonaryconcepts Llc alimentos, sistemas, métodos e estojos para provisão de substituição de eletrólito
KR20180041230A (ko) * 2015-09-01 2018-04-23 코로나리콘셉츠 엘엘씨 완하제 제제 및 제조
EP3473183A4 (en) 2016-06-15 2020-02-12 Shimadzu Corporation RADIATION IMAGING DEVICE
FR3056109B1 (fr) 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN112386577B (zh) * 2019-08-16 2024-01-23 北京天衡药物研究院有限公司 一种治疗便秘的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
PL210707B1 (pl) * 2003-02-28 2012-02-29 Alk Abello As Liofilizowana nie sprasowana szybko dyspergująca stała postać dawkowania
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
JP5276435B2 (ja) * 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ, インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento

Also Published As

Publication number Publication date
NL2007716C2 (en) 2012-11-13
NL2007716A (en) 2012-05-07
US20170296575A1 (en) 2017-10-19
ES2405531A2 (es) 2013-05-31
WO2012059724A8 (en) 2013-06-06
AR083769A1 (es) 2013-03-20
ES2405531R1 (es) 2013-06-07
NZ611148A (en) 2015-09-25
BE1019493A3 (fr) 2012-07-03
EP2635264B1 (en) 2018-05-30
AU2011324995B2 (en) 2015-12-24
ES2405531B1 (es) 2014-06-11
EP2635264B8 (en) 2018-07-18
EA201300539A1 (ru) 2013-09-30
MY164204A (en) 2017-11-30
US20160193245A1 (en) 2016-07-07
EA024566B1 (ru) 2016-09-30
JP5872573B2 (ja) 2016-03-01
WO2012059724A1 (en) 2012-05-10
SG190018A1 (en) 2013-06-28
CA2816835A1 (en) 2012-05-10
EP2635264A1 (en) 2013-09-11
CN103384516B (zh) 2017-02-15
MX342181B (es) 2016-09-20
AU2011324995A1 (en) 2013-05-02
MX2013004972A (es) 2013-08-27
KR20130101102A (ko) 2013-09-12
TWI520730B (zh) 2016-02-11
TW201223522A (en) 2012-06-16
US20130225692A1 (en) 2013-08-29
JP2014500246A (ja) 2014-01-09
BR112013010884A2 (pt) 2016-08-02
CN103384516A (zh) 2013-11-06

Similar Documents

Publication Publication Date Title
IL223206A0 (en) Vaccine formulations
IL221409A0 (en) Abuse-resistant formulations
IL225415A0 (en) Electrolytic formulations
EP2547333A4 (en) STABLE BORTEZOMIB FORMULATIONS
GB2481881B (en) Liquid formulations
IL225892A0 (en) Formulations containing polyethylene glycol
SI2605757T1 (sl) Formulacije na osnovi nalbufina in njihove uporabe
ZA201109485B (en) Polymers for high-surfactant formulations
PL2576690T3 (pl) Kompozycja polietylenowa
PL2359816T3 (pl) Formulacje aripiprazolu
ZA201300194B (en) Formulations
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
ZA201300196B (en) Formulations
ZA201304053B (en) Formulations comprising polyethylene glycol
GB201012589D0 (en) Formulations
GB201008358D0 (en) Formulations
GB201007702D0 (en) Formulations
GB201008470D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201007959D0 (en) Formulations
GB201018649D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201018647D0 (en) Formulations